In-line revenue, thanks to a seasonally strong quarter for HCL Software and a pick-up in ER&D; Positive surprise on margin on ...

December quarter results for fiscal 2024-25 (Q3FY25), India's leading information technology (IT) giants will be in focus ...

HCL Technologies Q3 results are estimated to be strong with a revenue growth expected to be 4.5% on a sequential basis driven ...

The board of directors of HCL Technologies Ltd will meet on 13 January 2025 to consider and approve the company's unaudited ...

HCL Tech will also declare a fourth interim dividend for the fiscal. Experts are forecasting an uptick in revenue and EBIT ...

Included in the HCL deal are such IBM products as IBM Appscan, a security-focused application for identifying and managing vulnerabilities in mission-critical applications; IBM BigFix endpoint ...

HCL Tech is expected to be the growth leader among Tier I, with about 4.6-5.5 per cent sequential constant currency (CC) ...

Anand Rathi recommended hold rating on HCL Technologies with a target price of Rs 2050 in its research report dated January ...

HCL Technologies' consolidated net profit jumped 8.41% to Rs 4,591 crore on 3.56% increase in net sales to Rs 29,890 crore in Q3 FY25 over Q2 FY25.

HCL Technologies, India’s third-largest IT services company by market capitalization, is projected to report a year-on-year ...

HCL Technologies along with 13 other companies will be releasing its financial performance result for the quarter that ended ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical group, today announces that it has entered an exclusive commercial partnership with Emergent BioSolutions (Emergent) for the sale of ...